Nanditha S, Iyer GaneshKrishnan K T, Raghu B, Prashanth Y M, Yadav Vikas
Department of Cardiac Anesthesia, Aster CMI, Bangalore, India.
Department of Cardiothoracic Surgery, Aster CMI, Bangalore, India.
Indian J Thorac Cardiovasc Surg. 2020 Jul;36(4):420-422. doi: 10.1007/s12055-020-00950-z. Epub 2020 May 11.
Fungal endocarditis following Extracorporeal membrane oxygenation (ECMO) is rare and very rarely reported. Though rare it has a high mortality rate. A 49-year-old male patient who had venovenous ECMO presented with aortic valve endocarditis after 40 days. He underwent sutureless bioprosthehtic valve placement and debridement of abscess. Abscess fluid grew aspergillus species and was started on dual antifungal intravenous amphotericin and variconazole. He was discharged after 1 month with oral variconazole. Incidence of aseptic endocarditis (AE) has been on rise due to increase in invasive procedures. Blood culture is mostly sterile, and fever may be absent. Abscess debridement and aggressive dual antifungal treatment helped our patient in his road to recovery. In current era with increasing use of ECMO, newer rarer complications should be kept in mind. High index of suspicion is required for diagnosing fungal endocarditis after ECMO.
体外膜肺氧合(ECMO)后发生真菌性心内膜炎很罕见,报道极少。尽管罕见,但死亡率很高。一名49岁接受静脉-静脉ECMO的男性患者在40天后出现主动脉瓣心内膜炎。他接受了无缝生物人工瓣膜置换及脓肿清创术。脓肿液培养出曲霉菌种,开始静脉给予两性霉素和伏立康唑联合抗真菌治疗。1个月后他口服伏立康唑出院。由于侵入性操作增加,无菌性心内膜炎(AE)的发病率一直在上升。血培养大多无菌,可能无发热。脓肿清创及积极的联合抗真菌治疗帮助我们的患者康复。在当前ECMO使用增加的时代,应牢记更新的罕见并发症。ECMO后诊断真菌性心内膜炎需要高度怀疑指数。